Search Press releases Keywords From To 2 Aug 2010 UCB delivers solid growth from its new medicines Cimzia, Vimpat and Neupro Read More 2 Aug 2010 UCB : Forte croissance grâce aux nouveaux médicaments Cimzia®, Vimpat® et Neupro® Read More 2 Aug 2010 UCB vertoont duurzame groei dankzij zijn nieuwe geneesmiddelen Cimzia®, Vimpat® en Neupro® Read More 30 Jul 2010 UCB to out-license six established products to Actient Pharmaceuticals, LLC Read More 23 Jul 2010 E Keppra (levetiracetam) receives regulatory approval in Japan Read More 23 Jul 2010 E Keppra® (ou lévétiracétam) obtient l’approbation des autorités japonaises Read More Pagination First page Previous page Previous … Page 158 Page 159 Page 160 Page 161 Current page 162 Page 163 Page 164 Page 165 Page 166 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
